Dexamethasone and Dexmedetomidine as an Adjuvant to Spinal Anesthesia for Elective Caesarean Sections
Launched by BENHA UNIVERSITY · Jan 5, 2021
Trial Information
Current as of May 05, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists classII-III adult female patient (age :18 -40 years old )
- • Elective cesarean section under spinal anaesthesia
- • Gestational age \> 37 weeks
- • BMI less than 30 kg/m2
- Exclusion Criteria:
- • Patient refusal
- • unable to give consent
- • age \< 18 or \> 40
- • BMI more than 30 kg/m2
- • known allergy to the study medication
- • coagulopathies or on anticoagulant medications
- • diabetic neuropathy
- • patients with psychiatric disorders
About Benha University
Benha University, a leading institution in Egypt, is dedicated to advancing medical research and innovation through rigorous clinical trials. With a strong emphasis on multidisciplinary collaboration, the university aims to enhance healthcare outcomes by exploring novel therapeutic approaches and interventions. Its state-of-the-art facilities and commitment to ethical research practices ensure that all trials are conducted with the highest standards of integrity and scientific rigor. Benha University actively contributes to the global medical community by fostering partnerships and disseminating findings that can improve patient care and inform public health policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials